Kohei Kawakami

Tailored eradication therapy based on fecal<i>Helicobacter pylori</i>clarithromycin sensitivities

Takashi Kawai, Tetsuya Yamagishi, Kenji Yagi et al. · Journal of Gastroenterology and Hepatology · 2008 · 67 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Prevalence of <i><scp>H</scp>elicobacter pylori</i> infection with healthy subjects in <scp>J</scp>apan

Yoji Hirayama, Takashi Kawai, Junji Otaki et al. · Journal of Gastroenterology and Hepatology · 2014 · 55 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +12

Comparison of the effects on cardiopulmonary function of ultrathin transnasal versus normal diameter transoral esophagogastroduodenoscopy in Japan.

Takashi Kawai, Ikuko Miyazaki, Kenji Yagi et al. · PubMed · 2007 · 53 citations

Medicine, Clinical Sciences, Surgery +16

Current status of first- and second-line <i>Helicobacter pylori</i> eradication therapy in the metropolitan area: a multicenter study with a large number of patients

Hideki Mori, Hidekazu Suzuki, Fumio Omata et al. · Therapeutic Advances in Gastroenterology · 2019 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Changes in the first line <i><scp>H</scp>elicobacter pylori</i> eradication rates using the triple therapy–a multicenter study in the <scp>T</scp>okyo metropolitan area (Tokyo <i>Helicobacter pylori</i> study group)

Takashi Kawai, Shinʼichi Takahashi, Hidekazu Suzuki et al. · Journal of Gastroenterology and Hepatology · 2014 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13